Diagnosis and prognosis for the Ewing family of tumors

Bibliography

• Enneking WF. Clinical musculoskeletal pathology. Gainsville (FL): storter printing company, 1996. p. 375-80
   Google Scholar
• Huvos AG. Bone tumors: diagnosis, treatment, and prognosis. Philadelphia: WB Saunders company, 1991. p. 523-52
   Google Scholar
• Campanacci M. Bone and soft tissue tumors. Wien New York: Springer-Verlag, 1999. p. 653-82
   Google Scholar
• Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors–a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294-99
   PubMed Web of Science ®Google Scholar
• Barroca H. Fine needle biopsy and genetics, two allied weapons in the diagnosis, prognosis, and target therapeutics of solid pediatric tumors. Diagn Cytopathol 2008;36:678-84
   PubMed Web of Science ®Google Scholar
• Llombart-Bosch A, Carda C, Peydro-Olaya A, et al. Soft tissue Ewing's sarcoma. Characterization in established cultures and xenografts with evidence of a neuroectodermic phenotype. Cancer 1990;66:2589-601
   PubMed Web of Science ®Google Scholar
• Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999;341:342-52
   PubMed Web of Science ®Google Scholar
• Huntington RW Jr, Henkelmann CR, Franklin R. Atypical Ewing tumor in the sister of a patient with Ewing's tumor. Clinical and autopsy finding. J Bone Joint Surg Am 1961;43:572-74
   Web of Science ®Google Scholar
• Huntington RW Jr, Sheffel DJ, Iger M, et al. Malignant bone tumors in sibilings. Ewing's tumor and an unusual tumor, perhaps a variant of Ewing's tumor. A case repost. J Bone Joint Surg Am 1969;43:1065-75
   Google Scholar
• Glass AG, Fraumeni JF Jr. Epidemiology of bone cancer in children. J Natl Cancer Inst 1970;44:187-99
   PubMed Web of Science ®Google Scholar
• Ginsberg JP, Woo SY, Mark E, et al. Ewing's sarcoma family of tumors: Ewing's sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In: Pizzo PA, Poplack DG, editors, Principles and practice of pediatric oncology, Philadelphia, PA: Lippincott, 2001. p. 973-1008
   Google Scholar
• Li FP, Tu JT, Liu FS, et al. Rarity of Ewing's sarcoma in China. Lancet 1980;1:1255
   PubMedGoogle Scholar
• Bacci G, Balladelli A, Forni C, et al. Ewing's sarcoma family tumours. Differences in clinicopathological characteristics at presentation between localized and metastatic tumours. J Bone Joint Surg Br 2007;89:1229-33
   PubMedGoogle Scholar
• Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000;18:3108-14
   PubMed Web of Science ®Google Scholar
• Craft AW, Cotterill SJ, Bullimore JA, et al. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer 1997;33:1061-69
   PubMed Web of Science ®Google Scholar
• Oberlin O, Deley MC, Bui BN, et al. French society of paediatric oncology. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French society of paediatric oncology (EW88 study). Br J Cancer 2001;85:1646-54
   PubMed Web of Science ®Google Scholar
• Parham DM, Hijazi Y, Steinberg SM, et al. Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior. Hum Pathol 1999;30:911-18
   PubMed Web of Science ®Google Scholar
• Paulussen M, Ahrens S, Burdach S, et al. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 1998;9:275-81
   PubMed Web of Science ®Google Scholar
• Turc-Carel C, Aurias A, Mugneret F, et al. Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet 1988;32:229-38
   PubMed Web of Science ®Google Scholar
• Fletcher CDM, Unni KK, Mertens F. World health organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002. p. 297-300
   Google Scholar
• Bacci G, Longhi A, Ferrari S, et al. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Acta Oncol 2006;45:469-75
   PubMed Web of Science ®Google Scholar
• Völker T, Denecke T, Steffen I, et al. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 2007;25:5435-41
   PubMed Web of Science ®Google Scholar
• de Alava E, Lozano MD, Patiño A, et al. Ewing family tumors: potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples. Diagn Mol Pathol 1998;7:152-7
   PubMed Web of Science ®Google Scholar
• Bernstein ML, Devidas M, Lafreniere D, et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457–a report from the Children's Oncology Group. J Clin Oncol 2006;24:152-59
   PubMed Web of Science ®Google Scholar
• Cangir A, Vietti TJ, Gehan EA, et al. Ewing's sarcoma metastatic at diagnosis. Cancer 1990;66:887-93
   PubMed Web of Science ®Google Scholar
• Paulussen M, Ahrens S, Dunst J, et al. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001;19:1818-29
   PubMed Web of Science ®Google Scholar
• Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694-701
   PubMed Web of Science ®Google Scholar
• Elomaa I, Blomqvist C, Saeter G, et al. Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 1999;285:69-73
   PubMedGoogle Scholar
• Göbel V, Jürgens H, Etspüler G, et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 1987;113:187-91
   PubMed Web of Science ®Google Scholar
• Hayes FA, Thompson EI, Meyer WH, et al. Therapy for localized Ewing's sarcoma of bone. J Clin Oncol 1989;7:208-13
   PubMed Web of Science ®Google Scholar
• Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto ortopedico rizzoli. J Clin Oncol 2000;18:4-11
   PubMed Web of Science ®Google Scholar
• Nesbit ME Jr, Gehan EA, Burgert EO Jr, et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol 1990;8:1664-74
   PubMed Web of Science ®Google Scholar
• Paulussen M, Craft AW, Lewis I, et al. European Intergroup Cooperative Ewing's Sarcoma Study-92. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment–cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J Clin Oncol 2008;26:4385-89
   PubMed Web of Science ®Google Scholar
• Rodríguez-Galindo C, Liu T, Krasin MJ, et al. Analysis of prognostic factors in Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer 2007;110:375-84
   PubMed Web of Science ®Google Scholar
• Bacci G, Ferrari S, Longhi A, et al. Prognostic significance of serum LDH in Ewing's sarcoma of bone. Oncol Rep 1999;6:807-11
   PubMed Web of Science ®Google Scholar
• Bramer JA, Abudu AA, Grimer RJ, et al. Do pathological fractures influence survival and local recurrence rate in bony sarcomas? Eur J Cancer 2007;43:1944-51
   PubMed Web of Science ®Google Scholar
• Picci P, Rougraff BT, Bacci G, et al. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol 1993;11:1763-69
   PubMed Web of Science ®Google Scholar
• Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 2004;40:73-83
   PubMed Web of Science ®Google Scholar
• Lin PP, Jaffe N, Herzog CE, et al. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma. Cancer 2007;109:603-11
   PubMed Web of Science ®Google Scholar
• Ferrari S, Bertoni F, Palmerini E, et al. Predictive factors of histologic response to primary chemotherapy in patients with Ewing sarcoma. J Pediatr Hematol Oncol 2007;29:364-68
   PubMed Web of Science ®Google Scholar
• de Alava E, Kawai A, Healey JH, et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 1998;16:1248-55
   PubMed Web of Science ®Google Scholar
• Zoubek A, Dockhorn-Dworniczak B, Delattre O, et al. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 1996;14:1245-51
   PubMed Web of Science ®Google Scholar
• Huang HY, Illei PB, Zhao Z, et al. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol 2005;23:548-58
   PubMed Web of Science ®Google Scholar